Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by kuatolives


ARLZQ

RE:Bear Raid #2

Wonder why. Maybe just vulnerable?

March 7, 2017

ARLZQ

RE:RE:RE:Stock price

Yes, it's disapointing that for all of the hot air from Harris, Goldman...

March 6, 2017

ARLZQ

RE:RE:RE:RE:RE:RE:RE:RE:RE:Earnings announcement soon...

I don't think many will care about 2016 as much as the 2017 projection...

February 28, 2017

ARLZQ

RE:RE:RE:RE:RE:RE:RE:Earnings announcement soon...

for 130M in earnings, $2 would put it at roughly 1x earnings, which I doubt...

February 28, 2017

ARLZQ

RE:RE:RE:RE:RE:Earnings announcement soon...

I think 2017 will be the end of this ride for me if profitability isn't...

February 24, 2017

ARLZQ

RE:RE:RE:Earnings announcement soon...

They also usually announce it one or two weeks in advance, which is why I was...

February 23, 2017

ARLZQ

Earnings announcement soon...

I hope?

February 21, 2017

V.BTI

RE:RE:RE:RE:RE:RE:RE:It has to be management

It's laughable that you think any layperson can get a "grip" on...

February 9, 2017

V.BTI

RE:RE:RE:RE:RE:It has to be management

What would be the point of signing a licensing agreement when in the time it...

February 9, 2017

ARLZQ

RE:RE:Aralez takes Teva to Court over yospralla

Guess it costs them very little to try. But yeah, maybe there is something to...

January 25, 2017

ARLZQ

Aralez takes Teva to Court over yospralla

http://www.lifesciencesipreview.com/news/aralez-sues-teva-over-yosprala...

January 25, 2017

ARLZQ

RE:RE:RE:RE:stock price jump

Heh the rest of the year will depend on the 2017 projection, when they...

January 23, 2017

ARLZQ

RE:RE:stock price jump

One can always hope the spring is starting to uncoil.

January 20, 2017

ARLZQ

RE:RE:RE:Yosprala

Yup, just gotta wait for the numbers while pharma keeps getting hammered. My...

January 17, 2017

T.MSL

RE:James Hodgins

PHM, Concordia, Valeant, Merus, Nobilis..... these are the greatest hits of...

December 19, 2016

ARLZQ

RE:RE:RE:RE:RE:Taken from the Globe & Mail stocks to watch

Just for sh!ts and giggles, here are the chain of ARLZ events since Sept 16th...

December 19, 2016

ARLZQ

RE:RE:RE:RE:Taken from the Globe & Mail stocks to watch

Levee will break one of these days. Still the best name in the sector. Merus,...

December 19, 2016

ARLZQ

ARLZ added to Nasdaq biotech index

http://ir.aralez.com/phoenix.zhtml?c=254163&p=irol-newsArticle&ID...

December 19, 2016

ARLZQ

RE:RE:Taken from the Globe & Mail stocks to watch

Amazing how this stock can't seem to sustain a rally. So many sellers at...

December 16, 2016

ARLZQ

RE:Taken from the Globe & Mail stocks to watch

Good news. 

December 15, 2016

Featured Company